Similarly, the up-regulation of COX-2 in colorectal cancer leads to production of PGE2 which binds to the EP3 receptor leading to PI3K and PKB activation, phosphorylation and dissociation of GSK3β and thereby inhibition of the destruction complex [26] (Figure 4C). Here, PTGS2 is linked to colorectal cancer.